article thumbnail

American Heart Association Announces New 2024-2025 National Volunteer Leaders

DAIC

The American Heart Association, commemorating its 100th year, has announced its volunteer leadership for fiscal year 2024-2025, which includes Keith Churchwell, MD, FAHA, a cardiologist renowned as a health equity champion, and Marsha Jones, an executive leader in workplace diversity and inclusion. in Pittsburgh.

article thumbnail

Top 10 AI Cardiometabolic Startups to Watch in 2025 

Cardiometabolic Health Congress

These innovative companies leverage AI to develop cutting-edge diagnostic tools, predictive analytics, and personalized medicine approaches. This exciting overview highlights the top 10 AI-powered cardiometabolic startups poised to make significant impacts in 2025.

article thumbnail

SS Innovations’ SSi Mantra Surgical Robotic System used to perform Mitral Valve Replacement

DAIC

milla1cf Mon, 03/18/2024 - 07:30 March 18, 2024 — SS Innovations International, Inc. , Dr. Srivastava said: “SS Innovations is dedicated to improving patient access and optimizing surgical outcomes with our accessible and cost-effective surgical robotic system. The mitral valve disease market size was valued at $2.5 from 2022 to 2031.

article thumbnail

Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix

DAIC

mtaschetta-millane Mon, 07/29/2024 - 09:02 July 29, 2024 — Edwards Lifesciences announced investments that reflect the company’s deep commitment to advancing patient care through structural heart innovation, addressing large unmet patient needs and supporting sustainable long-term growth. JenaValve presented positive results of its U.S.

article thumbnail

Johnson and Johnson Completes Acquisition of Shockwave Medical

DAIC

Joaquin Duato , Chairman and Chief Executive Officer of Johnson & Johnson, said, “Through Innovative Medicine and MedTech, Johnson & Johnson is transforming the trajectory of cardiovascular disease, one of the leading causes of death globally. in 2024 and approximately $0.17

article thumbnail

Edwards Lifesciences to Acquire Innovalve

DAIC

Combined with Edwards’ existing mitral innovations, the acquisition enhances the company’s TMVR technologies to address large unmet structural heart patient needs and support sustainable long-term growth. Edwards’ SAPIEN M3 remains on track to become the first approved transfemoral TMVR system in Europe by the end of 2025.

article thumbnail

Primary Prevention Takes Center Stage at the 19th Annual Cardiometabolic Health Congress (CMHC)

Cardiometabolic Health Congress

The Hilton Boston Park Plaza became a hub of innovation, education, and collaboration, uniting nearly 500 clinicians under a shared mission: to redefine cardiometabolic care. The 19th Annual CMHC was more than just CME/CE medical education—it ignited global collaboration and inspired groundbreaking innovations. Learn more now!

CME 64